BASKING RIDGE, N.J., June 04, 2019 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company ...

Please provide your email address to receive an email when new articles are posted on . Almost one-third of patients with psoriasis also had coronary microvascular dysfunction (CMD). Psoriasis ...

A new review highlights the potential role of single nucleotide polymorphisms (SNPs) in improving the early diagnosis and targeted intervention of coronary microvascular dysfunction (CMD)—a condition ...

Coronary microvascular dysfunction (CMD) affects 4 million people worldwide, impacting more women than men. Despite how common this heart condition is, it is often overlooked in patients. CMD is ...

CMD-related SNPs. CMD, coronary microvascular dysfunction; SNP, single nucleotide polymorphism. The findings suggest that a genetics-driven approach could revolutionize CMD diagnosis and treatment, ...

Empagliflozin reduced proinflammatory cytokines and oxidative stress markers in INOCA patients with CMD, improving vascular health. Treatment led to favorable shifts in endothelial extracellular ...

Garden-variety exercise stress testing can be used in patients who have angina with nonobstructive coronary arteries (ANOCA) to uncover the presence of coronary microvascular dysfunction (CMD), new ...

In a large cross-sectional study, nearly one third of patients with severe psoriasis met criteria for coronary microvascular dysfunction. Prior studies with small sample sizes have shown that coronary ...

PHILADELPHIA — In patients with angina but no obstructive coronary artery disease (CAD), low coronary flow reserve (CFR) detected in the cath lab can provide a clear diagnosis of coronary ...

Invasive coronary functional testing to identify the cause of angina in patients with nonobstructive coronary artery disease (ANOCA) can be performed safely at both experienced and less-experienced ...